ImpediMed Ltd
ASX:IPD

Watchlist Manager
ImpediMed Ltd Logo
ImpediMed Ltd
ASX:IPD
Watchlist
Price: 0.042 AUD -2.33% Market Closed
Market Cap: 85.1m AUD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one IPD stock under the Base Case scenario is 0.063 AUD. Compared to the current market price of 0.042 AUD, ImpediMed Ltd is Undervalued by 34%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IPD Relative Value
Base Case
0.063 AUD
Undervaluation 34%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7.4
P/S
P/S
Price to Sales
7.4
vs History
95
vs Industry
16
Median 3Y
15.5
Median 5Y
15.5
Industry
2.2
Forward
5.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-8.2
Median 5Y
-7.1
Industry
22.5
Forward
-4.9
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-10.4
Median 5Y
-8.4
Industry
13.9
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-7.7
Median 5Y
-7.1
Industry
19.7
More Details
2.6
P/B
P/B
Price to Book Value
2.6
vs History
79
vs Industry
30
Median 3Y
3.5
Median 5Y
3.5
Industry
2.1
More Details
5.7
EV/S
EV/S
Enterprise Value to Sales
5.7
vs History
93
vs Industry
19
Median 3Y
11.6
Median 5Y
12
Industry
2.3
Forward
4.2
More Details
6.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.5
vs History
95
vs Industry
29
Median 3Y
13.8
Median 5Y
16
Industry
4.9
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-6.1
Median 5Y
-5.5
Industry
11.9
Forward
-5.7
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-6.1
Median 5Y
-5.5
Industry
16.4
Forward
-4.4
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-7.8
Median 5Y
-7.2
Industry
13.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-5.9
Median 5Y
-5.9
Industry
17.2
More Details
3.3
EV/IC
EV/IC
Enterprise Value to IC
3.3
vs History
95
vs Industry
21
Median 3Y
7.2
Median 5Y
7.9
Industry
1.8
More Details

Multiples Across Competitors

IPD Competitors Multiples
ImpediMed Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
ImpediMed Ltd
ASX:IPD
83m AUD 7.4 -4 -3 -3
US
Abbott Laboratories
NYSE:ABT
226.5B USD 5.4 16.9 22.6 33.1
US
Intuitive Surgical Inc
NASDAQ:ISRG
175.2B USD 21 75.4 58.4 70.8
US
Boston Scientific Corp
NYSE:BSX
146.4B USD 8.7 79 36.1 51
US
Stryker Corp
NYSE:SYK
138.7B USD 6.1 46.3 24 29
IE
Medtronic PLC
NYSE:MDT
112.5B USD 3.4 26.4 14.1 19.9
US
Becton Dickinson and Co
NYSE:BDX
66B USD 3.2 37.7 15.7 28.3
DE
Siemens Healthineers AG
XETRA:SHL
56.7B EUR 2.5 28.6 16.3 23.3
US
Edwards Lifesciences Corp
NYSE:EW
41.7B USD 7.7 10 23.5 25.9
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
286.4B CNY 7.7 23.1 20.2 20.2
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.6B USD 1.9 18.3 12.8 15.7

See Also

Summary
IPD intrinsic value, competitors valuation, and company profile.
DCF Valuation
IPD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IPD stock valuation using valuation multiples.
Wall Street Estimates
IPD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IPD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 242,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.